Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q4 2026 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$63.72M$63.72Mderived+2.6% vs Q4 2025 Net Income-$4.14M-$4.14MderivedN/M vs Q4 2025 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$42,205,000+9.9% Operating Incomederived$2,748,000+87.1% Operating Cash Flowderived$13,962,000+10.2% Free Cash Flowderived$13,545,000+13.7% Margins · derivedGross margin66.2%+4.4 pt vs Q4 2025
Operating margin4.3%+1.9 pt vs Q4 2025
Net margin-6.5%+5.0 pt vs Q4 2025
ended Mar 31, 2026 · filed Jun 3, 2026 · 64 d after period end